Figure 5A–E demonstrates that the levels of all examined tumor biomarkers were significantly elevated in EAC-treated mice, including alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), cancer antigen 15-3 (CA15-3), cancer antigen 125 (CA125), and carbohydrate antigen 19-9 (CA19-9). Here, CEACAM5 is linked to neoplasm.